IMI2 | Future topics

 

Em janeiro de 2019 foram oficialmente divulgados e abertos os tópicos para a apresentação de propostas à Call 17, sobre os seguintes temas:

• Optimising future obesity treatment
• Open access chemogenomics library and chemical probes for the druggable genome
• Intelligent prediction and identification of environmental risks posed by human medicinal products

A par, fez-se já saber que se prevê lançar, previsivelmente a 26 de junho de 2019, uma seguinte Call com novos tópicos que, neste momento, se encontram em considerção, podendo ser modificados ou nem chegarem a ser incluídos no lançamento final. São eles:

1.Neurodegeneration and other neuroscience priorities

• Digital transformation of clinical trial endpoints in pain
• Placebo effect in pain
• Psychiatric ratings using intermediate stratified markers -2 (PRISM-2)

 

2.Immunology

• Psoriatic arthritis

 

3.Infection control including vaccines

• New topic(s) under the AMR accelerator platform

 

4.Translational safety

• Dosing in specific populations
• Digital pathology

 

5.Big data, digital health, clinical trials and regulatory research

• ROADMAP 2: need and opportunity for public-private collaborative research to continue the RoadMap efforts
• Independent observatories of health outcomes for patients being the guardians of health data
• E-product information. Leveraging digital technology to drive the correct use and understanding of medicines: a user-centric approach to adherence and risk minimisation

 

6.Oncology

• Patient-reported outcomes and quality of life endpoints

 

7.Facilitating the translation of advanced therapies to patients in Europe

• Accelerating research and development of Advanced Therapies
• ATMP Patient Registries Outcomes Data and Evidence
• CAR-Ts
• Innovative Manufacturing of Advanced Therapeutic Medicinal Products, ATMPs

 

8.Other enablers of research topics

• Handling of biologic drug products

 

Consulte aqui todos estes tópicos mais detalhados.

O CREATING HEALTH seguirá atentamente os próximos desenvolvimentos e todas as novidades! Conte com o nosso apoio!